Literature DB >> 632566

Relationship between lymphocyte response to tetanus toxoid and age of lymphocyte donor.

M M Peel, G Edsall, W G White, G M Barnes.   

Abstract

An investigation of the in vitro responsiveness of peripheral blood lymphocytes to tetanus toxoid was undertaken to determine the extent to which such reactivity might reflect in vivo reactions to tetanus toxoid immunization. It was found that lymphocyte transformation in the presence of tetanus toxoid, as measured by the uptake of tritiated thymidine, did not differ significantly for the group giving local or systemic reactions to tetanus toxoid and an immune control group. However, a striking inverse relation between lymphocyte reactivity to tetanus toxoid and age of the cell donors of both groups became clear. Such an age-related decline in the in vitro responsiveness of peripheral blood lymphocytes to a specific antigen has apparently had not been reported previously in man.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 632566      PMCID: PMC2129998          DOI: 10.1017/s0022172400053614

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  20 in total

1.  Thymus dependence of the antibody response to tetanus toxoid in mice.

Authors:  H N Willcox
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

2.  Human lymphocyte mitogenic factor: synthesis by sensitized thymus-derived lymphocytes, dependence of expression on the presence of antigen.

Authors:  R S Geha; E Merler
Journal:  Cell Immunol       Date:  1974-01       Impact factor: 4.868

3.  Lymphocyte phytohemagglutinin responsiveness, immunoglobulins and autoantibodies in aging humans.

Authors:  H M Hallgren; C E Buckley; V A Gilbertsen; E J Yunis
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

4.  Induction of DNA synthesis in normal human lymphocyte cultures by antigen-antibody complexes.

Authors:  G Möller
Journal:  Clin Exp Immunol       Date:  1969-01       Impact factor: 4.330

5.  A rapid micro-method for the phytohaemagglutinin-induced human lymphocyte transformation test.

Authors:  W J Penhale; A Farmer; A C Maccuish; W J Irvine
Journal:  Clin Exp Immunol       Date:  1974-09       Impact factor: 4.330

6.  Standardization of lymphocyte transformation to phytohaemagglutinin.

Authors:  M Yamamura
Journal:  Clin Exp Immunol       Date:  1973-07       Impact factor: 4.330

7.  The serological assessment of a tetanus toxoid field trial.

Authors:  K W Newell; D R Leblanc; G Edsall; L Levine; H Christensen; M H Montouri; N Ramirez
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

8.  Identification and characterization of subpopulations of lymphocytes in human peripheral blood after fractionation on discontinuous gradients of albumin. The cellular defect in X-linked agammaglobulinemia.

Authors:  R S Geha; F S Rosen; E Merler
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

9.  Reactions to tetanus toxoid.

Authors:  W G White; G M Barnes; E Barker; D Gall; P Knight; A H Griffith; R M Morris-Owen; J W Smith
Journal:  J Hyg (Lond)       Date:  1973-06

10.  Impaired lymphocyte function in aged humans.

Authors:  M E Weksler; T H Hütteroth
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

View more
  3 in total

1.  Age-related effects on the number of human lymphocytes in culture initially responding to an antigenic stimulus.

Authors:  P G Sohnle; C Collins-Lech; K E Huhta
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

2.  Aging and the immune response to tetanus toxoid: diminished frequency and level of cellular immune reactivity to antigenic stimulation.

Authors:  D Schatz; T Ellis; E Ottendorfer; E Jodoin; D Barrett; M Atkinson
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

3.  Tetanus vaccination, antibody persistence and decennial booster: a serosurvey of university students and at-risk workers.

Authors:  M Borella-Venturini; C Frasson; F Paluan; D DE Nuzzo; G DI Masi; M Giraldo; F Chiara; A Trevisan
Journal:  Epidemiol Infect       Date:  2017-03-15       Impact factor: 4.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.